Comedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBase™.

Journal Article (Journal Article)

Polypharmacy is common, and may modify mechanisms of drug-induced liver injury. We examined the effect of these drug-drug interactions on liver safety reports of four drugs highly associated with hepatotoxicity. In the WHO VigiBase™, liver event reports were examined for acetaminophen, isoniazid, valproic acid, and amoxicillin/clavulanic acid. Then, we evaluated the liver event reporting frequency of these 4 drugs in the presence of co-reported medications. Each of the 4 primary drugs was reported as having more than 2000 liver events, and co-reported with more than 600 different medications. Overall, the effect of 2275 co-reported drugs (316 drug classes) on the reporting frequency was analyzed. Decreased liver event reporting frequency was associated with 245 drugs/122 drug classes, including anti-TNFα, opioids, and folic acid. Increased liver event reporting frequency was associated with 170 drugs/82 drug classes; in particular, halogenated hydrocarbons, carboxamides, and bile acid sequestrants. After adjusting for age, gender, and other co-reported drug classes, multiple co-reported drug classes were significantly associated with decreased/increased liver event reporting frequency in a drug-specific/unspecific manner. In conclusion, co-reported medications were associated with changes in the liver event reporting frequency of drugs commonly associated with hepatotoxicity, suggesting that comedications may modify drug hepatic safety.

Full Text

Duke Authors

Cited Authors

  • Suzuki, A; Yuen, NA; Ilic, K; Miller, RT; Reese, MJ; Brown, HR; Ambroso, JI; Falls, JG; Hunt, CM

Published Date

  • August 2015

Published In

Volume / Issue

  • 72 / 3

Start / End Page

  • 481 - 490

PubMed ID

  • 25988394

Pubmed Central ID

  • PMC4548888

Electronic International Standard Serial Number (EISSN)

  • 1096-0295

Digital Object Identifier (DOI)

  • 10.1016/j.yrtph.2015.05.004


  • eng

Conference Location

  • Netherlands